BNP Paribas Financial Markets’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $477K | Buy |
|
|||||
|
2025
Q2 | $633K | Buy |
|
|||||
|
2025
Q1 | $603K | Sell |
|
|||||
|
2024
Q4 | $424K | Buy |
|
|||||
|
2024
Q3 | $549K | Buy |
|
|||||
|
2024
Q2 | $642K | Buy |
|
|||||
|
2024
Q1 | $142K | Buy |
|
|||||
|
2023
Q4 | $48.3K | Sell |
|
|||||
|
2023
Q3 | $62.5K | Sell |
|
|||||
|
2023
Q2 | $127K | Buy |
|
|||||
|
2023
Q1 | $65.6K | Buy |
|
|||||
|
2022
Q4 | $57.7K | Sell |
|
|||||
|
2022
Q3 | $986K | Buy |
|
|||||
|
2022
Q2 | $96.6K | Sell |
|
|||||
|
2022
Q1 | $1.47M | Buy |
|
|||||
|
2021
Q4 | $1.4M | Buy |
|
|||||
|
2021
Q3 | $179K | Buy |
|
|||||
|
2021
Q2 | $53.5K | Sell |
|
|||||
|
2021
Q1 | $186K | Buy |
|
|||||
|
2020
Q4 | $242K | Sell |
|
|||||
|
2020
Q3 | $306K | Buy |
|
|||||
|
2020
Q2 | $156K | Sell |
|
|||||
|
2020
Q1 | $1.23M | Buy |
|
|||||
|
2019
Q4 | $279K | Sell |
|
|||||
|
2019
Q3 | $240K | Buy |
|
|||||
|
2019
Q2 | $176K | Sell |
|
|||||
|
2019
Q1 | $382K | Buy |
|
|||||
|
2018
Q4 | $33.8K | Sell |
|
|||||
|
2018
Q3 | $109K | Buy |
|
|||||
|
2018
Q2 | $130K | Sell |
|
|||||
|
2018
Q1 | $310K | Buy |
|
|||||
|
2017
Q4 | $171K | Buy |
|
|||||
|
2017
Q3 | $74.2K | Sell |
|
|||||
|
2017
Q2 | $67.9K | Buy |
|
|||||
|
2017
Q1 | $6.76K | Sell |
|
|||||
|
2016
Q4 | $7.26K | Sell |
|
|||||
|
2016
Q3 | $37.3K | Buy |
|
|||||
|
2016
Q2 | $22.3K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $189K | Buy |
|
|||||
|
2015
Q3 | $149K | Buy |
|
|||||
|
2015
Q2 | $63.9K | Buy |
|
|||||
|
2015
Q1 | $7.94K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $13.5K | Buy |
|